Accessibility Menu
Adagene logo

Adagene

(NASDAQ) ADAG

Current Price$3.46
Market Cap$157.32M
Since IPO (2021)-89%
5 Year-76%
1 Year+89%
1 Month-8%

Adagene Financials at a Glance

Market Cap

$157.32M

Revenue (TTM)

$7.80M

Net Income (TTM)

-$51.08M

EPS (TTM)

-$0.37

P/E Ratio

-8.87

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$3.46

Volume

295,329

Open

$3.56

Previous Close

$3.32

Daily Range

$3.16 - $3.56

52-Week Range

$1.30 - $4.75

Estimated Earnings Date

Sep 2, 2026

ADAG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Adagene

Industry

Biotechnology

Employees

128

CEO

Peizhi Luo, PhD

Headquarters

Suzhou, 215123, CN

ADAG Financials

Key Financial Metrics (TTM)

Gross Margin

92%

Operating Margin

-3%

Net Income Margin

-2%

Return on Equity

-34%

Return on Capital

-40%

Return on Assets

-23%

Earnings Yield

-11.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$157.32M

Shares Outstanding

47.39M

Volume

295.33K

Avg. Volume

256.35K

Financials (TTM)

Gross Profit

$7.67M

Operating Income

-$21.44M

EBITDA

-$16.85M

Operating Cash Flow

-$15.66M

Capital Expenditure

-$17.05K

Free Cash Flow

-$15.67M

Cash & ST Invst.

$74.52M

Total Debt

$6.26M

Adagene Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$7.69M

N/A

Gross Profit

$7.41M

N/A

Gross Margin

96.33%

N/A

Market Cap

$157.32M

N/A

Market Cap/Employee

$1.14M

N/A

Employees

138

N/A

Net Income

-$4.14M

+51.3%

EBITDA

-$5.48M

+38.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$68.26M

-8.8%

Accounts Receivable

$17.35K

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.19M

-74.5%

Short Term Debt

$5.07M

-68.5%

Return on Assets

-22.56%

N/A

Return on Invested Capital

-40.48%

N/A

Free Cash Flow

-$4.56M

+31.9%

Operating Cash Flow

-$4.55M

+32.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FBIOFortress Biotech, Inc.
$2.65-4.33%
GANXGain Therapeutics, Inc.
$1.70-8.60%
XBITXBiotech Inc.
$2.37+0.00%
NRXPNRx Pharmaceuticals, Inc.
$4.14+2.22%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$73.05-0.14%
KEELKeel Infrastructure
$5.13-0.13%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.19+0.14%
IBITiShares Bitcoin Trust
$34.14-0.05%

Questions About ADAG

What is the current price of Adagene?

Adagene is trading at $3.32 per share.

What is the 52-week range for Adagene?

Over the past 52 weeks, Adagene has traded between $1.30 and $4.75.

How much debt does Adagene have?

As of the most recent reporting period, Adagene reported total debt of $6.26M.

How much cash does Adagene have on hand?

Adagene reported $74.52M in cash and cash equivalents in its most recent financial results.

What is Adagene’s dividend yield?

Adagene does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.